10-Bromo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine

Catalog No. :
ACHWVT537
CAS No. :
1282516-56-6
Molecular Formula :
C11H9BrN2O
Molecular Weight :
265.11

IUPAC Name:10-bromo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine

10-Bromo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$124.00Login to see priceIn stockInquiry
250mg95%$226.00Login to see priceIn stockInquiry
1g95%$443.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name10-Bromo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
IUPAC Name10-bromo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
Molecular FormulaC11H9BrN2O
Molecular Weight265.11
SMILESBrC1=CC=C(OCCN2C3=NC=C2)C3=C1
InChI KeyQZWGGYOQEOZRJK-UHFFFAOYSA-N
Synonym10-broMo-5,6-dihydrobenzo[f]iMidazo[1,2-d][1,4]oxazepine;10-BROMO-5,6-DIHYDROIMIDAZO[1,2-D][1,4]BENZOXAZEPINE;Imidazo[1,2-d][1,4]benzoxazepine, 10-bromo-5,6-dihydro-;10-Bromo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine - [B94781]
CAS No.1282516-56-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACHWVT537 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHWVT537 route product structure diagram
    ACHWVT5371282516-56-6 In Stock
Inquiry

2. ACHWVT537 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNFRO850 route compound structure diagram
    ACNFRO850289506-17-8 In Stock
  4. Then
  5. ACHWVT537 route product structure diagram
    ACHWVT5371282516-56-6 In Stock
Inquiry

Comments (0)